BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1777616)

  • 21. Effect of acute ethanol ingestion on human gastric luminal prostaglandin E2, prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha.
    Bode C; Ganzhorn A; Brauner B; Bode JC
    Alcohol Alcohol; 1989; 24(1):35-42. PubMed ID: 2920071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peptic lesions of the upper gastrointestinal tract].
    Weidenhiller S
    Fortschr Med; 1974 Feb; 92(5):201-3. PubMed ID: 4595001
    [No Abstract]   [Full Text] [Related]  

  • 23. [The etiopathogenesis and therapy of gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1978 Sep; 86(6):515-35. PubMed ID: 367685
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of the relationship between portal hypertension and gastroduodenal mucosal lesions.
    Mitani S; Yoshida J; Saitoh M; Asaka M; Matsushima T; Miyazaki T
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():146-50. PubMed ID: 2519034
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of various types of vagotomy on prostaglandins (E, F2 alpha), thromboxane and prostacyclin synthesis in the mucosa of the gastroduodenal zone in experimental ulcer in the rat].
    Morenkova SA; Tabutsadze TU; Fedorova LM
    Vopr Med Khim; 1988; 34(1):109-12. PubMed ID: 3285586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Etiology and pathogenesis of chronic gastric and duodenal ulcer].
    Palasz M
    Wiad Lek; 1974 Jul; 27(14):1279-83. PubMed ID: 4608764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Campylobacter pylori (C. pylori): an occasional finding or a constant pathogenetic factor in peptic and inflammatory gastroduodenal pathology? Personal observations].
    Licata A; Naso P; Bartoloni G; Bonanno G; Di Gaetano G; Torcetta N
    Minerva Dietol Gastroenterol; 1990; 36(3):133-7. PubMed ID: 2280870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisecretory and antiulcer properties of prostaglandins.
    Robert A
    Compr Ther; 1978 Jul; 4(7):10-3. PubMed ID: 668288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric mucosal somatostatin-like immunoreactivity in peptic ulcer.
    Torres AJ; Fernandez-Durango R; Suarez A; Ariznavarreta C; Hernandez F; Cuberes R; Ortega L; Balibrea JL
    Surg Gynecol Obstet; 1987 Apr; 164(4):313-8. PubMed ID: 3563843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pathogenesis of peptic ulcer of the stomach and duodenum].
    Samsonov VA
    Arkh Patol; 1972; 34(10):3-11. PubMed ID: 4573521
    [No Abstract]   [Full Text] [Related]  

  • 31. Newer concepts in the pathogenesis of peptic ulcer disease.
    Ippoliti A; Walsh J
    Surg Clin North Am; 1976 Dec; 56(6):1479-90. PubMed ID: 793065
    [No Abstract]   [Full Text] [Related]  

  • 32. [Duodenal and gastric ulcers in liver diseases].
    Hasik J; Rajewska J; Rzymski K; Kiczka M
    Pol Tyg Lek; 1975 Dec; 30(48):2001-3. PubMed ID: 1197082
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostaglandins and the pathogenesis of duodenal ulcer: no correlation with gastric mucosal PGE2 content.
    Ligumsky M; Sharon P; Karmeli F; Rachmilewitz D
    Isr J Med Sci; 1979 Feb; 15(2):171-3. PubMed ID: 468529
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandins in pathophysiology of peptic ulcer disease.
    Konturek SJ
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):105S-108S. PubMed ID: 3863751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of specific binding of prostaglandin E2, prostaglandin F2 alpha, and 6-keto prostaglandin F1 alpha to serum in patients with peptic ulcer disease and in healthy subjects.
    Redfern JS; Feldman M
    Gastroenterology; 1986 Jul; 91(1):71-4. PubMed ID: 3458638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endogenous prostaglandin E2 levels in the gastric mucosa of patients with stomach ulcer].
    Rácz I; Téri N; Jávor T
    Orv Hetil; 1986 May; 127(21):1247-51. PubMed ID: 3523372
    [No Abstract]   [Full Text] [Related]  

  • 37. Endogenous prostaglandins in peptic ulcer disease.
    Baker R; Jaffe BM; Venables CW
    Gut; 1979 May; 20(5):394-9. PubMed ID: 468069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radioimmunoassay of prostaglandins (author's transl)].
    Peskar BM
    Z Gastroenterol; 1978 May; 16(5):341-8. PubMed ID: 654390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of endogenous prostacyclin-level in different experimental gastroduodenal ulcer models of rat.
    Balint GA; Náfrádi J; Varró V
    Agents Actions; 1986 Mar; 17(5-6):495-7. PubMed ID: 3518358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of local factors regulating vascular blood flow in the development of hypoxia of the gastric mucosa in peptic ulcer].
    Pasechnikov VD; Ermolaeva NIu; Virganskiĭ AO
    Ter Arkh; 1988; 60(12):74-7. PubMed ID: 3247660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.